Combined Influence of Waist and Hip Circumference on Risk of Death in a Large Cohort of European and Australian Adults.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
07 07 2020
Historique:
pubmed: 1 7 2020
medline: 10 3 2021
entrez: 1 7 2020
Statut: ppublish

Résumé

Background Waist circumference and hip circumference are both strongly associated with risk of death; however, their joint association has rarely been investigated. Methods and Results The MONICA Risk, Genetics, Archiving, and Monograph (MORGAM) Project was conducted in 30 cohorts from 11 countries; 90 487 men and women, aged 30 to 74 years, predominantly white, with no history of cardiovascular disease, were recruited in 1986 to 2010 and followed up for up to 24 years. Hazard ratios were estimated using sex-specific Cox models, stratified by cohort, with age as the time scale. Models included baseline categorical obesity measures, age, total and high-density lipoprotein cholesterol, systolic blood pressure

Identifiants

pubmed: 32602397
doi: 10.1161/JAHA.119.015189
pmc: PMC7670538
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e015189

Subventions

Organisme : Medical Research Council
ID : G0601463
Pays : United Kingdom
Organisme : Medical Research Council
ID : 80983
Pays : United Kingdom

Références

Circulation. 2010 Jan 26;121(3):384-91
pubmed: 20065160
Curr Opin Lipidol. 2018 Aug;29(4):285-292
pubmed: 29994839
Int J Epidemiol. 2012 Apr;41(2):484-94
pubmed: 22266094
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Obesity (Silver Spring). 2014 Mar;22(3):957-63
pubmed: 23963732
Am J Epidemiol. 2009 Apr 1;169(7):837-47
pubmed: 19224980
BMJ. 2009 Sep 03;339:b3292
pubmed: 19729416
Int J Obes Relat Metab Disord. 1995 Sep;19(9):644-52
pubmed: 8574275
BMJ. 1996 Feb 10;312(7027):377
pubmed: 8611847
Int J Behav Nutr Phys Act. 2013 Aug 08;10:94
pubmed: 23924209
Br Med J (Clin Res Ed). 1984 May 12;288(6428):1401-4
pubmed: 6426576
PLoS One. 2012;7(7):e39504
pubmed: 22815707
Obesity (Silver Spring). 2013 Jan;21(1):E78-85
pubmed: 23404691
Int J Obes Relat Metab Disord. 2004 Mar;28(3):402-9
pubmed: 14724659
Circulation. 2018 Mar 27;137(13):1391-1406
pubmed: 29581366
Circulation. 2008 Feb 12;117(6):743-53
pubmed: 18212285
Circulation. 2007 Dec 18;116(25):2933-43
pubmed: 18071080
Int J Epidemiol. 2005 Feb;34(1):21-7
pubmed: 15561751
Obes Rev. 2013 Jan;14(1):86-94
pubmed: 23072327
N Engl J Med. 2008 Nov 13;359(20):2105-20
pubmed: 19005195
Am J Clin Nutr. 2009 Apr;89(4):1213-9
pubmed: 19190072
Obes Rev. 2012 Mar;13(3):275-86
pubmed: 22106927
Int J Epidemiol. 2017 Dec 1;46(6):2044-2055
pubmed: 28369345
J Am Heart Assoc. 2020 Jul 7;9(13):e015189
pubmed: 32602397
Int J Obes Relat Metab Disord. 2004 Jun;28(6):741-7
pubmed: 15052280
Int J Obes (Lond). 2010 Jun;34(6):949-59
pubmed: 20065965
Int J Obes Relat Metab Disord. 1999 Feb;23(2):116-25
pubmed: 10078844

Auteurs

Adrian J Cameron (AJ)

Global Obesity Centre Institute for Health Transformation Deakin University Geelong Australia.

Helena Romaniuk (H)

Biostatistics Unit Faculty of Health Deakin University Geelong Australia.

Liliana Orellana (L)

Biostatistics Unit Faculty of Health Deakin University Geelong Australia.

Jean Dallongeville (J)

Unité d'Epidémiologie et de Santé Publique Inserm-U1167 Institut Pasteur de Lille Lille France.

Annette J Dobson (AJ)

School of Public Health University of Queensland Herston Queensland Australia.

Wojciech Drygas (W)

Department of Epidemiology CVD Prevention and Health Promotion Cardinal Wyszynski National Institute of Cardiology Warsaw Poland.

Marco Ferrario (M)

Department of Medicine and Surgery, Research Center in Epidemiology and Preventive Medicine University of Insubria Varese Italy.

Jean Ferrieres (J)

Department of Cardiology Toulouse University School of Medicine Toulouse France.

Simona Giampaoli (S)

Department of Cardiovascular Endocrine-Metabolic Diseases and Aging Istituto Superiore di Sanità Rome Italy.

Francesco Gianfagna (F)

Mediterranea Cardiocentro Napoli Italy.
Department of Medicine and Surgery, Research Center in Epidemiology and Preventive Medicine University of Insubria Varese Italy.
University of Insubria Varese Italy.

Licia Iacoviello (L)

Department of Epidemiology and Prevention Istituto di Ricovero e Cura a Carattere Scientifico Neuromed Pozzilli Italy.
Department of Medicine and Surgery, Research Center in Epidemiology and Preventive Medicine University of Insubria Varese Italy.
University of Insubria Varese Italy.

Pekka Jousilahti (P)

Department of Public Health Solutions Finnish Institute for Health and Welfare Helsinki Finland.

Frank Kee (F)

Centre for Public Health Institute for Health Sciences Queen's University, School of Medicine, Dentistry and Biomedical Sciences Belfast Northern Ireland.

Marie Moitry (M)

Department of Public Health University Hospital of Strasbourg France.
Department of Epidemiology and Public Health University of Strasbourg France.

Teemu J Niiranen (TJ)

Department of Public Health Solutions Finnish Institute for Health and Welfare Helsinki Finland.
Department of Medicine Turku University Hospital and University of Turku Turku Finland.

Andrzej Pająk (A)

Department of Epidemiology and Population Studies Jagiellonian University Medical College Kraków Poland.

Luigi Palmieri (L)

Department of Cardiovascular Endocrine-Metabolic Diseases and Aging Istituto Superiore di Sanità Rome Italy.

Tarja Palosaari (T)

Department of Public Health Solutions Finnish Institute for Health and Welfare Helsinki Finland.

Männistö Satu (M)

Department of Public Health Solutions Finnish Institute for Health and Welfare Helsinki Finland.

Abdonas Tamosiunas (A)

Department of Population Studies Institute of Cardiology Lithuanian University of Health Sciences Kaunas Lithuania.

Barbara Thorand (B)

German Research Center for Environmental Health Institute of Epidemiology Helmholtz Zentrum München Neuherberg Germany.

Ulla Toft (U)

Center for Clinical Research and Prevention Bispebjerg and Frederiksberg Hospital Copenhagen Denmark.

Diego Vanuzzo (D)

Cardiovascular Prevention Centre Udine Italy.

Salomaa Veikko (S)

Department of Public Health Solutions Finnish Institute for Health and Welfare Helsinki Finland.

Giovanni Veronesi (G)

Department of Medicine and Surgery, Research Center in Epidemiology and Preventive Medicine University of Insubria Varese Italy.

Tom Wilsgaard (T)

Department of Community Medicine The Arctic University of Norway Tromsø Norway.

Kari Kuulasmaa (K)

Department of Public Health Solutions Finnish Institute for Health and Welfare Helsinki Finland.

Stefan Söderberg (S)

Department of Public Health and Clinical Medicine, and Heart Centre Umeå University Umeå Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH